Search research articles
Contact Us
Filters
Showing results (291-300 of 387) with videos related to
Page
of 39
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 13, 2014
Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis
Jose L Calleja, Juan M Pascasio, Belén Ruiz-Antorán, et al.
Genomics, Proteomics & Bioinformatics
|
May 4, 2026
Calling for Diversity: Improving Transfusion Safety Through High-Throughput Blood Group Microarray Genotyping
Michael Wittig, Tim Alexander Steiert, Hesham ElAbd, et al.
Journal of Hepatology
|
December 19, 2015
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
George Papatheodoridis, George Dalekos, Vana Sypsa, et al.
Scientific Reports
|
February 6, 2024
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death
Francesca Minnai, Filippo Biscarini, Martina Esposito, et al.
Digestive Diseases and Sciences
|
October 17, 2018
Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis
Sang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, et al.
Hepatology (Baltimore, Md.)
|
August 12, 2020
Analysis of Hepatitis B Virus Haplotype Diversity Detects Striking Sequence Conservation Across Genotypes and Chronic Disease Phase
Josef Wagner, Lilly Yuen, Margaret Littlejohn, et al.
Gut
|
July 12, 2014
Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians
Pauline Arends, Milan J Sonneveld, Roeland Zoutendijk, et al.
Digestive Diseases and Sciences
|
August 24, 2018
Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis
Sang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, et al.
Journal of Gastroenterology and Hepatology
|
March 25, 2016
Flares during long-term entecavir therapy in chronic hepatitis B
Heng Chi, Pauline Arends, Jurriën G P Reijnders, et al.
Gastroenterology
|
November 18, 2017
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals
Julia Dietz, Simone Susser, Johannes Vermehren, et al.
Page
of 39
Search research articles
Search
Showing results (291-300 of 387) with videos related to
Sort By:
Page
of 39
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 13, 2014
Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis
Jose L Calleja, Juan M Pascasio, Belén Ruiz-Antorán, et al.
Genomics, Proteomics & Bioinformatics
|
May 4, 2026
Calling for Diversity: Improving Transfusion Safety Through High-Throughput Blood Group Microarray Genotyping
Michael Wittig, Tim Alexander Steiert, Hesham ElAbd, et al.
Journal of Hepatology
|
December 19, 2015
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
George Papatheodoridis, George Dalekos, Vana Sypsa, et al.
Scientific Reports
|
February 6, 2024
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death
Francesca Minnai, Filippo Biscarini, Martina Esposito, et al.
Digestive Diseases and Sciences
|
October 17, 2018
Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis
Sang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, et al.
Hepatology (Baltimore, Md.)
|
August 12, 2020
Analysis of Hepatitis B Virus Haplotype Diversity Detects Striking Sequence Conservation Across Genotypes and Chronic Disease Phase
Josef Wagner, Lilly Yuen, Margaret Littlejohn, et al.
Gut
|
July 12, 2014
Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians
Pauline Arends, Milan J Sonneveld, Roeland Zoutendijk, et al.
Digestive Diseases and Sciences
|
August 24, 2018
Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis
Sang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, et al.
Journal of Gastroenterology and Hepatology
|
March 25, 2016
Flares during long-term entecavir therapy in chronic hepatitis B
Heng Chi, Pauline Arends, Jurriën G P Reijnders, et al.
Gastroenterology
|
November 18, 2017
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals
Julia Dietz, Simone Susser, Johannes Vermehren, et al.
Page
of 39